Your browser doesn't support javascript.
loading
Stress Hyperglycemia in Patients With Acute Ischemic Stroke Due to Large Vessel Occlusion Undergoing Mechanical Thrombectomy.
Merlino, Giovanni; Pez, Sara; Gigli, Gian Luigi; Sponza, Massimo; Lorenzut, Simone; Surcinelli, Andrea; Smeralda, Carmelo; Valente, Mariarosaria.
Afiliação
  • Merlino G; Stroke Unit, Department of Neuroscience, Udine University Hospital, Udine, Italy.
  • Pez S; Clinical Neurology, Udine University Hospital, Udine, Italy.
  • Gigli GL; Clinical Neurology, Udine University Hospital, Udine, Italy.
  • Sponza M; Dipartimento di Area Medica (DAME), University of Udine, Udine, Italy.
  • Lorenzut S; Clinical Neurology, Udine University Hospital, Udine, Italy.
  • Surcinelli A; Dipartimento di Area Medica (DAME), University of Udine, Udine, Italy.
  • Smeralda C; Division of Vascular and Interventional Radiology, Udine University Hospital, Udine, Italy.
  • Valente M; Stroke Unit, Department of Neuroscience, Udine University Hospital, Udine, Italy.
Front Neurol ; 12: 725002, 2021.
Article em En | MEDLINE | ID: mdl-34659090
ABSTRACT
Stress hyperglycemia may impair outcomes in patients with acute ischemic stroke (AIS) undergoing mechanical thrombectomy (MT). The glucose-to-glycated hemoglobin ratio (GAR) was used to measure stress hyperglycemia. Data from our database of consecutive patients admitted to the Udine University Hospital with AIS who were treated with MT between January 2015 and December 2020 were retrospectively analyzed. We included 204 patients in the study and stratified them into four groups according to the quartiles of GAR (Q1-Q4). The higher the GAR index, the more severe the stress hyperglycemia was considered. Patients with more severe stress hyperglycemia showed a higher prevalence of 3-month poor outcome (Q1, 53.1%; Q2, 40.4%; Q3, 63.5%; Q4, 82.4%; p = 0.001), 3-month mortality (Q1, 14.3%; Q2, 11.5%; Q3, 15.4%; Q4, 31.4%; p = 0.001), and symptomatic intracranial hemorrhage (Q1, 2%; Q2, 7.7%; Q3, 7.7%; Q4, 25.4%; p = 0.001). After controlling for several confounders, severe stress hyperglycemia remained a significant predictor of 3-month poor outcome (OR 4.52, 95% CI 1.4-14.62, p = 0.012), 3-month mortality (OR 3.55, 95% CI 1.02-12.29, p = 0.046), and symptomatic intracranial hemorrhage (OR 6.89, 95% CI 1.87-25.36, p = 0.004). In summary, stress hyperglycemia, as measured by the GAR index, is associated with a detrimental effect in patients with AIS undergoing MT.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Neurol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Neurol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália